how many americans take glp 1 drugs 12% of have used GLP-1 weight loss A new study reports a

At trial completion, the primary outcome occurred in 108 patients (6.6%) in the semaglutide group versus 146 patients (8.9%) in the placebo group (hazard ratio [HR]: 0.74

Larger studies are needed to confirm this, although these would be challenging or infeasible to conduct

For patients, this means navigating a more complex treatment landscape, where outcomes depend not only on the drug itself but on the system surrounding it

Leah Joseph How Does Ozempic Work Compared to Natural GLP1

Download our guide to Managing GLP-1 Costs and Supporting Optimal Health Outcomes for ideas on how to start building your own strategy now